Get the Stockscreener App
17.67
6.95%
-1.32
Electrocore Inc stock is traded at $17.67, with a volume of 208.88K.
It is down -6.95% in the last 24 hours and up +11.06% over the past month.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
See More
Previous Close:
$18.99
Open:
$18.91
24h Volume:
208.88K
Relative Volume:
1.73
Market Cap:
$117.61M
Revenue:
$16.03M
Net Income/Loss:
$-18.83M
P/E Ratio:
-5.0486
EPS:
-3.5
Net Cash Flow:
$-14.87M
1W Performance:
+1.49%
1M Performance:
+11.06%
6M Performance:
+191.10%
1Y Performance:
+151.35%
1-Day Range:
$17.05
$19.49
1-Week Range:
$17.05
$19.49
52-Week Range:
$5.32
$19.49
Electrocore Inc Stock (ECOR) Company Profile
Name
Electrocore Inc
Sector
Industry
Phone
973-290-0097
Address
200 FORGE WAY, ROCKAWAY
Compare ECOR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ECOR
Electrocore Inc
|
17.67 | 117.61M | 16.03M | -18.83M | -14.87M | -3.50 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-14-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-14-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-26-19 | Resumed | Cantor Fitzgerald | Neutral |
| May-30-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-15-19 | Downgrade | BTIG Research | Buy → Neutral |
| May-09-19 | Initiated | Noble Capital Markets | Outperform |
| Sep-21-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Electrocore Inc Stock (ECOR) Latest News
electroCore’s Truvaga™ Now Available on Amazon® - GlobeNewswire
ElectroCore expands reach with Amazon listing for Truvaga Plus By Investing.com - Investing.com South Africa
ElectroCore expands reach with Amazon listing for Truvaga Plus - Investing.com India
electroCore's Truvaga™ Now Available on Amazon® - The Manila Times
This FDA-Cleared Device Claims to Reduce Stress and Improve SleepNow Available on Amazon - StockTitan
electroCore Insider Buyers See Boost After Market Cap Rose US$11m - Simply Wall St
ElectroCore stock soars to 52-week high, hits $18.77 - Investing.com India
ElectroCore stock soars to 52-week high, hits $18.77 By Investing.com - Investing.com South Africa
What Makes electroCore (ECOR) a High Growth And High Margin Business? - Insider Monkey
electroCore, Inc. (NASDAQ:ECOR) Short Interest Up 34.5% in January - MarketBeat
How to Take Advantage of moves in (ECOR) - Stock Traders Daily
Vagus Nerve Stimulators Market Witness Growth: Booming Demand, - openPR
electroCore (ECOR) Is a Great Choice for 'Trend' Investors, Here's Why - Nasdaq
electroCore secures two new US patents for nerve therapy - MSN
electroCore secures two new US patents for nerve therapy By Investing.com - Investing.com Nigeria
electroCore Expands Intellectual Property Portfolio - GlobeNewswire
Breakthrough Patents Bolster electroCore's Nerve Stimulation Tech: Smart Monitoring Meets Precision Treatment - StockTitan
electroCore to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - GlobeNewswire
Exclusive: electroCore Leadership Takes Center Stage at Elite BTIG Healthcare Summit - StockTitan
Short Interest in electroCore, Inc. (NASDAQ:ECOR) Drops By 22.8% - MarketBeat
Insider Stock Buying Reaches US$675.8k On electroCore - Yahoo Finance UK
Here's Why Momentum in electroCore (ECOR) Should Keep going - Yahoo Finance
When the Price of (ECOR) Talks, People Listen - Stock Traders Daily
Vagus Nerve Stimulators Market is Estimated to Grow at a CAGR - openPR
electroCore (NASDAQ:ECOR) Announces Preliminary Financial Results for Q4 2024 and Full Year - Defense World
Short Interest in electroCore, Inc. (NASDAQ:ECOR) Decreases By 22.8% - MarketBeat
Vagus Nerve Stimulators Market Growth in Future Scope 2025-2032 - openPR
electroCore: An Opportunity In Medical And Wellness Device Innovation (NASDAQ:ECOR) - Seeking Alpha
electroCore, Inc.'s (NASDAQ:ECOR) last week's 14% decline must have disappointed individual investors who have a significant stake - Simply Wall St
Geode Capital Management LLC Raises Stock Holdings in electroCore, Inc. (NASDAQ:ECOR) - Defense World
Contrasting CONMED (NYSE:CNMD) & electroCore (NASDAQ:ECOR) - Defense World
International Assets Investment Management LLC Has $895,000 Holdings in electroCore, Inc. (NASDAQ:ECOR) - MarketBeat
electroCore announces 5 new U.S. patents - MSN
electroCore Receives 5 New U.S. Patents - MPO-mag
electroCore Secures 5 Groundbreaking Patents for Nerve Stimulation Medical Breakthroughs - StockTitan
ElectroCore stock soars to 52-week high, hits $17.98 By Investing.com - Investing.com South Africa
ElectroCore stock soars to 52-week high, hits $17.98 - Investing.com
electroCore, Inc.'s (NASDAQ:ECOR) largest shareholders are individual investors with 58% ownership, insiders own 22% - Yahoo Finance
Here’s Why Rogue Funds is Excited on Electrocore (ECOR) - Insider Monkey
electroCore Inc (ECOR) Shares Gap Down to $16.07 on Dec 31 - GuruFocus.com
electroCore Has Only Just Begun To Scratch The Surface Of Its Huge TAM (ECOR) - Seeking Alpha
Electrocore Inc Stock (ECOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Electrocore Inc Stock (ECOR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| GANDOLFO JOHN P | Director |
Jun 13 '24 |
Buy |
6.43 |
1,000 |
6,430 |
50,704 |
| Goldberger Daniel S | Chief Executive Officer |
Jun 05 '24 |
Buy |
6.43 |
38,505 |
247,587 |
249,565 |
1.16%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):